quinazolines has been researched along with Libman-Sacks Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C; Wang, Y; Wei, P; Zhang, H; Zhang, L | 1 |
| Clark, WF; Moriarity, TA; Reid, BD; Tevaarwerk, GJ | 1 |
| Nissilä, M; Skrifvars, B | 1 |
1 trial(s) available for quinazolines and Libman-Sacks Disease
| Article | Year |
|---|---|
Immunological effects of Biarison in the treatment of rheumatoid arthritis and systemic lupus erythematosus. A preliminary report.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Sedimentation; Double-Blind Method; Drug Evaluation; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Indomethacin; Lupus Erythematosus, Systemic; Male; Middle Aged; Quinazolines; Time Factors | 1980 |
2 other study(ies) available for quinazolines and Libman-Sacks Disease
| Article | Year |
|---|---|
Inhibition of PI3Kδ improves systemic lupus in mice.
Topics: Adenine; Animals; Antibodies, Antinuclear; Chemokine CCL2; Class I Phosphatidylinositol 3-Kinases; Creatinine; Interleukin-17; Interleukin-1beta; Kidney; Kidney Function Tests; Liver; Lupus Erythematosus, Systemic; Male; Mice; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proteinuria; Proto-Oncogene Proteins c-akt; Quinazolines | 2014 |
Inhibitors of immune complex induced human platelet aggregation and release in plasma.
Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; DNA; Humans; Imidazoles; Indomethacin; Lupus Erythematosus, Systemic; Male; Platelet Aggregation; Quinazolines; Receptors, Fc; Sulfinpyrazone | 1982 |